-       Report 
- April 2023
-  75 Pages 
- India 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- August 2020
-  80 Pages 
- Chile 
   From       €2892EUR$3,250USD£2,546GBP 
          -       Report 
- July 2024
-  104 Pages 
- Middle East 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- July 2024
-  157 Pages 
- Europe 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- April 2024
-  70 Pages 
- Africa, Middle East 
   From       €3070EUR$3,450USD£2,702GBP 
           -       Report 
- April 2024
-  68 Pages 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- April 2024
-  86 Pages 
- Asia Pacific 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- April 2024
-  91 Pages 
- Europe 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- April 2024
-  85 Pages 
- North America 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- March 2024
-  103 Pages 
- Europe 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- March 2024
-  108 Pages 
- North America 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- March 2024
-  83 Pages 
- Middle East, Africa 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- March 2024
-  82 Pages 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- March 2024
-  95 Pages 
- Asia Pacific 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- February 2024
-  150 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- November 2023
-  204 Pages 
- Middle East, Europe 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- November 2023
-  205 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- September 2023
-  172 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- April 2024
-  130 Pages 
- Global 
   From       €3515EUR$3,950USD£3,094GBP 
          -       Report 
- January 2024
-  142 Pages 
- Global 
   From       €3782EUR$4,250USD£3,329GBP 
       
      The Spinal Cord Stimulator (SCS) is a type of medical device used to treat chronic pain in the lower back, neck, and limbs. It works by sending electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain. SCS is a form of neuromodulation, which is a type of therapy that uses electrical stimulation to modify nerve activity. It is used to treat a variety of conditions, including failed back surgery syndrome, complex regional pain syndrome, and peripheral neuropathy.
SCS    is a minimally invasive procedure, and is typically used when other treatments have failed. It is typically implanted in the lower back, and is connected to a small battery-powered device that is worn externally. The device is programmed to deliver electrical pulses to the spinal cord, which can help reduce pain signals sent to the brain.
The SCS market is a growing segment of the neurology devices market. It is expected to continue to grow as more patients seek out minimally invasive treatments for chronic pain.
Some companies in the SCS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less   Read more